5/24/2024  5:35:21 PM Chg. -0.140 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
18.380EUR -0.76% 30,981
Turnover: 568,059.720
18.040Bid Size: 600 18.480Ask Size: 212 1.35 bill.EUR 1.63% 18.95

Business description

Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.
 

Management board & Supervisory board

CEO
Rafael Padilla
Management board
Karin de Jong, Vera Bakker, Maarten Pouw, Andrew Pulido, Geraldino Neder, Johan Verlinden
Supervisory board
Koen Hoffman, Karin de Jong, Neeraj Sharma, Klaus Röhrig, Els Vandecandelaere, Rob ten Hoedt, Ann Desender
 

Company data

Name: Fagron NV
Address: Venecoweg 20A,BE-9810 Nazareth, Oost-Vlaanderen
Phone: +32 88 33 11 288
Fax: -
E-mail: -
Internet: https://investors.fagron.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: -
IPO date: 10/5/2007

Investor relations

Name: -
IR phone: +31 88 33 11 200
IR Fax: -
IR e-mail: investors@fagron.com

Company calendar

CW 31 | 8/1/2024 Interim Report 2nd Quarter/6 Months
CW 41 | 10/10/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
40.09%
The Goldman Sachs Group, Inc.
 
18.04%
NN Group N.V.
 
15.85%
AOC Pharma S.à.r.l.
 
11.06%
Mawer Investment Management Ltd.
 
5.02%
Alychlo NV
 
4.97%
FMR LLC
 
4.97%